相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advancing the global public health agenda for NAFLD: a consensus statement
Jeffrey Lazarus et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
Mohammad Shadab Siddiqui et al.
JOURNAL OF HEPATOLOGY (2020)
Inter-organ cross-talk in metabolic syndrome
Christina Priest et al.
NATURE METABOLISM (2019)
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
Na Jiao et al.
GUT (2018)
Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model
Francois Briand et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Distinguishing genetic correlation from causation across 52 diseases and complex traits
Luke J. O'Connor et al.
NATURE GENETICS (2018)
LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis
Jie Zheng et al.
BIOINFORMATICS (2017)
Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III
M. Ghosh Laskar et al.
JOURNAL OF INTERNAL MEDICINE (2017)
Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
Dirk J. Blom et al.
CIRCULATION (2017)
Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice
Kenta Takei et al.
JOURNAL OF DIABETES INVESTIGATION (2017)
PPARs and nonalcoholic fatty liver disease
Kim H. H. Liss et al.
BIOCHIMIE (2017)
Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers
R. Pencek et al.
DIABETES OBESITY & METABOLISM (2016)
Use of fibrates in the metabolic syndrome: A review
Kate E. Shipman et al.
WORLD JOURNAL OF DIABETES (2016)
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa
Eleonora Distrutti et al.
JOURNAL OF GASTROENTEROLOGY (2015)
ABCG5/ABCG8 in cholesterol excretion and atherosclerosis
Xiao-Hua Yu et al.
CLINICA CHIMICA ACTA (2014)
Characterization of European Ancestry Nonalcoholic Fatty Liver Disease-Associated Variants in Individuals of African and Hispanic Descent
Nicholette D. Palmer et al.
HEPATOLOGY (2013)
Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease
Michael S. Kostapanos et al.
WORLD JOURNAL OF HEPATOLOGY (2013)
The Cholesterol Content of Western Diets Plays a Major Role in the Paradoxical Increase in High-Density Lipoprotein Cholesterol and Upregulates the Macrophage Reverse Cholesterol Transport Pathway
Joan Carles Escola-Gil et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Role of nuclear receptor SHP in metabolism and cancer
Yuxia Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
Georg B. Ehret et al.
NATURE (2011)
Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease
Nobito Higuchi et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2011)
Biological, clinical and population relevance of 95 loci for blood lipids
Tanya M. Teslovich et al.
NATURE (2010)
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution
Iris M. Heid et al.
NATURE GENETICS (2010)
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
Elizabeth K. Speliotes et al.
NATURE GENETICS (2010)
The role of the lipogenic pathway in the development of hepatic steatosis
C. Postic et al.
DIABETES & METABOLISM (2008)
A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease
C. Fernandez-Miranda et al.
DIGESTIVE AND LIVER DISEASE (2008)
The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes
Takeshi Murakami et al.
BIOCHEMICAL JOURNAL (2007)
Cholangiocyte anion exchange and biliary bicarbonate excretion
Jesus M. Banales et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Sorting out the roles of PPARα in energy metabolism and vascular horneostasis
P Lefebvre et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus
PWF Wilson et al.
CIRCULATION (2005)
Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice
E Ip et al.
HEPATOLOGY (2004)
Noninvasive evaluation of graft steatosis in living donor liver transplantation
M Iwasaki et al.
TRANSPLANTATION (2004)
ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion
GA Graf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice
E Ip et al.
HEPATOLOGY (2003)
Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion
LQ Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A Val227Ala polymorphism in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene is associated with variations in serum lipid levels
K Yamakawa-Kobayashi et al.
JOURNAL OF MEDICAL GENETICS (2002)
分享论文
